Hagen Heidi — SEC Form 4 filings
SEC reporting owner CIK 1585084. 7 Form 4 filings on record with FilingPulse; latest filed 2026-08-05.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-05-03 to 2026-08-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 24,000 shares, $931,920 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 15,000 shares @ $32.41 ($486,150) in Vericel Corp, filed 2026-03-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vericel Corp (VCEL) | Director | 6 | — | 2 legs · 24,000 sh · $931,920 | 20 |
| Obsidian Therapeutics, Inc. (OBX) | Director | 1 | — | — | 1 |
Form 4 filings — Hagen Heidi
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-05 | 4 | Obsidian Therapeutics, Inc. (OBX) | Grant/award (A): 37,653 (derivative) @ $0 | EDGAR |
| 2026-05-01 | 4 | Vericel Corp (VCEL) | Option exercise (M): 3,200 · Option exercise (M): 3,200 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 · Grant/award (A): 3,200 (derivative) @ $0 | EDGAR |
| 2026-03-25 | 4 | Vericel Corp (VCEL) | Option exercise (M): 15,000 @ $2.76 · Sale (S): 15,000 @ $32.41 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | Vericel Corp (VCEL) | Option exercise (M): 3,200 · Option exercise (M): 3,200 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 · Grant/award (A): 3,200 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Vericel Corp (VCEL) | Option exercise (M): 9,000 @ $3.74 · Sale (S): 9,000 @ $49.53 · Option exercise (M): 9,000 (derivative) @ $0 | EDGAR |
| 2024-10-21 | 4 | Vericel Corp (VCEL) | Option exercise (M): 4,000 @ $3.74 · Option exercise (M): 6,000 @ $3.74 · Option exercise (M): 4,000 (derivative) @ $0 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | Vericel Corp (VCEL) | Option exercise (M): 3,200 · Option exercise (M): 3,200 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 · Grant/award (A): 3,200 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1585084 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →